Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Nivolumab
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Nivolumab
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Antibodies > Antibodies, Monoclonal > Antibodies, Monoclonal, Humanized > Nivolumab

Preferred term

Nivolumab  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • BMS 936558
  • BMS-936558
  • BMS936558
  • MDX 1106
  • MDX-1106
  • MDX1106
  • ONO 4538
  • ONO-4538
  • ONO4538
  • Opdivo

Scope note

  • A genetically engineered, fully humanized immunoglobulin G4 monoclonal antibody that binds to the PD-1 RECEPTOR, activating an immune response to tumor cells. It is used as monotherapy or in combination with IPILIMUMAB for the treatment of advanced malignant MELANOMA. It is also used in the treatment of advanced or recurring NON-SMALL CELL LUNG CANCER; RENAL CELL CARCINOMA; and HODGKIN'S LYMPHOMA.

History note

  • 2019 (2010)

In other languages

URI

http://www.yso.fi/onto/mesh/D000077594

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/18, last modified 2/28/20